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Abstract
Background: Antibody isotype responses can be useful as indicators of immune bias during infection. In studies of
parasite co-infection however, interpretation of immune bias is complicated by the occurrence of cross-reactive
antibodies. To confidently attribute shifts in immune bias to the presence of a co-infecting parasite, we suggest
practical approaches to account for antibody cross-reactivity. The potential for cross-reactive antibodies to influence
disease outcome is also discussed.
Results: Utilising two murine models of malaria-helminth co-infection we analysed antibody responses of mice
singly- or co-infected with Plasmodium chabaudi chabaudi and Nippostrongylus brasiliensis or Litomosoides
sigmodontis. We observed cross-reactive antibody responses that recognised antigens from both pathogens
irrespective of whether crude parasite antigen preparations or purified recombinant proteins were used in ELISA.
These responses were not apparent in control mice. The relative strength of cross-reactive versus antigen-specific
responses was determined by calculating antibody titre. In addition, we analysed antibody binding to periodate-
treated antigens, to distinguish responses targeted to protein versus carbohydrate moieties. Periodate treatment
affected both antigen-specific and cross-reactive responses. For example, malaria-induced cross-reactive IgG1
responses were found to target the carbohydrate component of the helminth antigen, as they were not detected
following periodate treatment. Interestingly, periodate treatment of recombinant malaria antigen Merozoite Surface
Protein-119 (MSP-119) resulted in increased detection of antigen-specific IgG2a responses in malaria-infected mice.
This suggests that glycosylation may have been masking protein epitopes and that periodate-treated MSP-119 may
more closely reflect the natural non-glycosylated antigen seen during infection.
Conclusions: In order to utilize antibody isotypes as a measure of immune bias during co-infection studies, it is
important to dissect antigen-specific from cross-reactive antibody responses. Calculating antibody titre, rather than
using a single dilution of serum, as a measure of the relative strength of the response, largely accomplished this.
Elimination of the carbohydrate moiety of an antigen that can often be the target of cross-reactive antibodies also
proved useful.
Background
The geographical and socio-economic distribution of
malaria overlaps with areas in which a number of hel-
minth parasites are also endemic. It is the norm in these
areas for co-infection to occur and a growing body of
literature reflects this [1-12]. The influence of co-infec-
tion on the immune response may result in either
exacerbation or amelioration of disease [13-15]. It is
therefore crucial to understand the host-parasite rela-
tionship in the context of multiple infections, if vaccine
design and drug administration programmes are to be
managed effectively [16]. Animal models accurately
reflect many pathological aspects of malaria-helminth
co-infection with regard to impact on disease outcome
and also provide the opportunity to further examine
immunological mechanisms in detail [17-20].
We previously undertook an investigation to assess the
impact of a pre-existing chronic nematode infection on
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Plasmodium chabaudi chabaudi (Pcc) and the rodent
filarial nematode Litomosoides sigmodontis (Ls) [21]. We
found that co-infected mice (Pcc-Ls), particularly those
that did not have blood microfilaremia, had exacerbated
immunopathology. This was associated with increased
interferon-gamma (IFN-g) responsiveness but was inde-
pendent of Pcc parasitemia [21]. One of the primary
objectives in our previous malaria-nematode co-infec-
tion studies was to gather antigen-specific T-cell data to
determine whether nematode infection could alter the
cytokine bias of the Pcc-specific T lymphocyte response
towards Th1 and conversely, whether a potent Th1
response could alter the Th2 bias of the nematode-spe-
cific response.
Cytokine production by antigen specific T-cells can be
difficult to assess during malaria, due to immune sup-
pression associated with the peak of infection and apop-
tosis of splenocytes [22]. Additionally, the complex
nature of the target antigen (Pcc-infected red blood
cells) is a further complicating factor. Thus, gathering
antigen-specific T-cell data remains a technical chal-
lenge of studying immunity to malaria particularly in
human studies where there is the additional challenge of
obtaining and maintaining lymphocytes in the field.
Here we focus on the dissection and interpretation of
parasite antigen-specific antibody responses as an alter-
native to T-cell analysis. Antibodies of the IgG2a isotype
are mainly produced by B cells in response to IFN-g in
mice [23-25] whereas the Th2 cytokine IL-4 switches B
cells to produce IgG1 [24,26]. Although the generation
of IgG1 as a marker for Th2 cells is less definitive than
IgG2a as a marker of a Th1-type response, the ratio of
IgG1 to IgG2a provides a powerful indicator of immune
bias [27-30]. Measurement of antibodies can also be
achieved with smaller sample volumes and poses fewer
technical challenges than T-cell recall assays. Further-
more, antibody analysis can provide information on the
fuller history of infection as it reflects cumulative immu-
nological activity, whereas cytokine responses of T-cells
are an ex-vivo ’snapshot’ that can more readily be
altered by changes in the timing of sampling both in
vivo and in vitro. Antibody analyses of co-infected ani-
mals might therefore providee v i d e n c eo fo v e r a l lT h 1 -
Th2 cell cross-regulation even when cytokine analyses
may not.
In addition to their use as indicators of cytokine bias
during infection, antibody isotypes have direct functional
relevance to disease severity in helminth-malaria co-
infection. Antibodies are absolutely required for the
ultimate clearance of malaria parasites [31]. In mice,
a n t i b o d i e so ft h ec y t o p h i l i ci s o t y p eI g G 2 ah a v eb e e n
shown to recognise infected erythrocytes [32] and facili-
tate their destruction by phagocytes [33]. Similarly, in
humans IgG1 and IgG3 are associated with enhanced
parasite clearance [34]. If helminth co-infection alters
antibody class-switching and consequently the produc-
tion of malaria-specific cytophilic antibodies then the
resolution of malaria infection may be affected. Indeed,
co-infection with the gastro-intestinal nematode Heligo-
mosoides polygyrus reduced Pcc-specific IgG2a responses
and resulted in exacerbated malaria parasitemia [18].
There are also important implications for vaccine effi-
cacy and administration. For example, immunisation
that protected mice from malaria failed to do so in mice
that also harboured a nematode infection [35].
In this study, the characterisation of antibody isotype
responses as an indicator of cytokine bias during co-
infection has proved unexpectedly challenging due to the
production of cross-reactive antibodies induced by sin-
gle-species infection. To establish the real effect of co-
infection on the Th1/Th2 immune bias from non-specific
reactivity to antigen we needed to determine how robust
the cross-reactive responses were in comparison to the
antigen-specific. We demonstrate that a combination of
calculating antibody titre, from a dilution series of test
sera, and periodate treatment of the parasite antigens can
control for most cross-reactivity. The magnitude and
robustness of some cross-reactivity, however merits
further investigation to explore the potential function of
these responses during co-infection.
Methods
Hosts, parasites and experimental infection
Specific pathogen free, 8-10 week old female BALB/c
mice (Harlan, UK) were maintained in individually ven-
tilated cages on diet 41b ad lib in a 12 h:12 h light-dark
cycle. All experiments were carried out in accordance
with the animals (Scientific Procedures) Act 1986, and
were approved by the UK Home Office inspectorate and
institutional review committee.
Pcc clone AS was originally isolated from thicket rats
(Thamnomys rutilans) and was cloned by serial dilution
and passage [36]. Parasites were recovered from frozen
blood stabilates by passage through donor mice. Experi-
mental parasite inoculations were prepared from donor
mice by diluting blood in calf serum solution (50% heat-
inactivated foetal calf serum, 50% Ringer’ss o l u t i o n[ 2 7
mM KCl, 27 mM CaCl2, 0.15 M NaCl, 20 units heparin
per mouse]). Each mouse received 0.1 ml of inoculum
intraperitoneally (i.p) corresponding to an infective dose
of 1 × 10
6 or 1 × 10
5 parasitized red blood cells (RBC),
depending on the experiment. An inoculum of naïve
RBC was given as a control for erythrocyte proteins.
The filarial nematode Ls was maintained by cyclical
passage between gerbils (Meriones unguiculatus)a n d
mites (Ornithonyssus bacoti) as described previously
[37]. Infection was initiated by subcutaneous (s.c)
Fairlie-Clarke et al. BMC Immunology 2010, 11:6
http://www.biomedcentral.com/1471-2172/11/6
Page 2 of 12injection of 25 infective (L3) larvae. For co-infection
experiments in which the influence of malaria on
chronic nematode infection was addressed, 1 × 10
6 Pcc
parasitized RBC were introduced i.p on Day 60 of an
established Ls infection and mice were sacrificed on day
20 post-Pcc infection, as described previously [21].
Whole blood was collected from the brachial artery and
serum recovered after clotting at room temperature.
Nb worms were maintained by serial passage through
Sprague-Dawley rats. L3 larvae were obtained by cultur-
ing the faeces of infected rats at 26°C for a minimum of
5 days [38]. For acute nematode-malaria co-infection,
infection was initiated by s.c injection of 200 infective
(L3) larvae on the same day that Pcc was introduced by
inoculation i.p of 1 × 10
5 parasitized RBC. Mice were
sacrificed on Day 20 post-infection under terminal
anaesthesia. Whole blood was collected from the bra-
chial artery and was separated using Sera Sieve (Hughes
& Hughes Ltd).
Antigens
Two malaria antigens were used in this study: a recom-
binant protein and a crude antigen homogenate pre-
pared from parasitized erythrocytes. The recombinant
Merozoite Surface Protein-119 (MSP-119) was originally
sequenced, cloned and expressed from Pcc AS clone, as
described previously [39]. In brief, the MSP-119 nucleo-
tide sequence was inserted into Pichia pastoris vector
pIC9K and protein expression carried out in Pichia pas-
toris strain SMD1169. This antigen was used in ELISA
at a concentration of 1 μg/ml.
T h ec r u d em a l a r i ah o m o g e n a t e-l y s e dPcc parasitized
red blood cell extract (pRBC) - was prepared from whole
blood of mice with a parasitemia in excess of 20%. Mice
were bled by cardiac puncture with a heparinised syringe
and blood stored at -80°C prior to 3 rounds of freeze-
thaw to lyse the parasitized red blood cells. The lysed
cells were sonicated, on ice, twice for 30 sec at 10 Amp
and centrifuged at 16060 g for 10 min. The supernatant
was stored at -80°C. Similarly, a naïve red blood cell
extract (nRBC) was prepared as a control for RBC pro-
teins; responses to this antigen amongst infected mice
were indistinguishable from naïve (data not shown). In
the Ls experiments this antigen was used in ELISA at 0.5
μg/ml and in the Nb experiments at 5 μg/ml.
Ls and Nb extracts (LsA and NbA) were prepared by
homogenisation of adult nematodes in PBS. The somatic
extracts were centrifuged at 1000 g for 20 mins and the
pellet discarded. The extract was stored at -20°C. LsA
was used in ELISA at 0.5 μg/ml and NbA at 5 μg/ml.
Antibody detection
ELISA was used to measure antigen-specific IgG antibo-
dies in the serum of nematode-infected, Pcc-infected or
co-infected mice. In the Pcc-Ls study, sera were added
in a serial dilution 1/100 - 1/400 and a dilution was
then chosen whereby all samples fell in the linear range
of the curve; for IgG1, a dilution of 1/200 and for IgG2a
1/100. For the subsequent Pcc-Nb study, serum samples
were added in a serial dilution 1/50 - 1/819200. Anti-
body titres were calculated as the reciprocal of the
greatest dilution at which optical density (O.D) was
greater than the mean plus 3 standard deviations of the
O.D values observed for control mouse sera at 1/200
dilution.
Antibody responses to MSP-119,p R B C ,N b Ao rL s A
were determined for IgG isotypes IgG1, IgG2a, and
IgG3. 96 well maxisorp immunoplates (Nunc) were
coated at 4°C overnight with either recombinant or
crude antigens at the concentrations indicated (see Anti-
gens section) in 0.06 M carbonate buffer (0.04 M
NaHCO3,0 . 0 2MN a C O 3,p H 9 . 6 )i naf i n a lv o l u m eo f
50 μl per well. Non-specific binding was blocked with
5% FCS in carbonate buffer (200 μl/well) for 2 hours at
37°C. Wells were washed three times in Tris buffered
saline with 0.1% Tween (TBST) after each step. Serum
samples were added in serial dilutions as indicated using
TBST as a diluent, in a final volume of 75 μlp e rw e l l
and incubated for 2 hours at 37°C. Isotype specific
detection antibodies were diluted in TBST in a final
volume of 50 μl per well. For IgG1, HRP conjugated
goat anti-mouse IgG1 (Southern Biotech 1070-05) was
used at 1/6000, HRP conjugated goat anti-mouse IgG2a
(Southern Biotech 1080-05) at 1/4000 and HRP conju-
gated goat anti-mouse IgG3 (Southern Biotech 1100-05)
was used at 1/1000. Plates were incubated for 1 hour at
37°C. An additional wash in distilled water was carried
out before developing with ABTS peroxide substrate
(Insight Biotechnology), 100 μl per well, at room tem-
perature for 20 minutes. O.D was read at 405 nm using
a spectrophotometer.
Polyclonal IgE levels were determined by sandwich
ELISA. 96 well maxisorp immunoplates (Nunc) were
coated overnight at 4°C with 100 μl of IgE capture anti-
body (2 μg/ml; clone R35-72 Pharmingen) diluted in
carbonate buffer. Plates were blocked with 5% non-fat
skimmed milk in carbonate buffer for 2 hr at 37°C.
Plates were washed 5 × in TBST before addition of sera
at 1/10 and 1/20 dilutions in a final volume of 50 μl/
well and left overnight at 4°C. For the standard curve
two- fold serial dilutions of purified mouse IgE, 
monoclonal isotype standard (Pharmingen) were used.
After 5 washes in TBST, 100 μl of biotinylated detection
antibody (2 μg/ml; clone R35-118 Pharmingen) diluted
in TBST with 5% FCS was added and plates left at 37°C
for 90 mins. Plates were washed 5 × in TBST prior to
incubation with ExtrAvidin peroxidase (SIGMA), diluted
1:8000 in TBST with 0.5% FCS, for 30 mins at 37°C.
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oped with 100 μl TMB microwell peroxidase substrate
system (Insight Biotechnology Ltd) and read at 650 nm.
In order to determine the extent to which carbohy-
drate or protein moieties contributed to the antibody
response the antigens were pre-treated with periodate.
Antigen-specific IgG1, IgG2a and IgG3 antibodies were
measured in response to antigens treated with periodate.
The ELISA was carried out as detailed for the Nb co-
infection experiment with untreated antigens but the
following additional steps were included after blocking
with 5% FCS: carbonate buffer, prior to sample addition.
TBST wash (×3) was followed by the addition of 10 mM
sodium (meta) periodate diluted in 50 mM sodium acet-
ate in a final volume of 100 μl/well. Plates were incu-
bated at 37°C for 1 hour and then washed in 50 mM
sodium acetate. To stop the activity of periodate, 100 μl
of 50 mM sodium borohydride solution was added to
each well.
Statistical Analysis
General linear statistical models allowed us to frame and
test questions such that we could determine whether
differences in infection status and/or presence of carbo-
hydrate antigen explained the observed variation in anti-
body responses. For more detailed explanation of the
statistical methods employed see Grafen and Hails [40].
Infection status and treatment with periodate (or not)
were included as categorical factors and their ability to
predict antibody response was formally evaluated via
Analysis of Variance (ANOVA). The serial dilution of
sera in an ELISA produces ordinal data, which were
log10 transformed prior to analysis to ensure the data
were approximately normally distributed, in accordance
with the requirements of linear models. Analyses were
carried out using the statistical package JMP 5.1 (SAS).
The maximal model was fitted first and minimal models
were obtained by sequentially removing non-significant
terms (P-value > 0.05), beginning with interactions.
Finally, whenever a factor was significant (P <0 . 0 5 ) ,a n
All Pairs Tukey post-hoc test was carried out to identify
which groups of mice differed significantly in antibody
induction, with respect to infection status or periodate
treatment.
Results
Antibody isotype responses are skewed by malaria-filaria
co-infection but cross-reactivity confounds data
interpretation
We had previously used a model of Pcc-nematode co-
infection in which Pcc is introduced into mice with pre-
existing chronic Ls infection to investigate the dynamics
of infection with regard to parasitological outcome and
cytokine bias [21]. In the Pcc-Ls model the peak of
malaria parasitemia was controlled by day 10 and
resolved by day 14 post Pcc-infection. For this study, we
envisaged that analysis of the antibody isotype response
from these mice would provide a method to rapidly and
quantitatively assess immune bias. We thus asked
whether we could use antibody isotype ELISA for IgG2a
and IgG1 to address whether nematode infection would
skew the Th1 cell response to Pcc t oam o r eT h 2c e l l
biased response. Conversely, we wished to address
whether the powerful Th1 cell response induced by
malaria would have the capacity to alter an established
IgG1 response to a nematodei n f e c t i o n .A si sc o m m o n
practice in many studies [41-48], especially with large
s a m p l es i z e sa si nt h i ss t u d y ,t h eE L I S A sw e r ep e r -
formed with a fixed serum concentration derived from
the linear point in a dilution series.
As expected from previous studies [49-51], we were
able to detect an IgG1 response against LsA in Ls mice.
Co-infected (Pcc-Ls) mice also produced LsA-specific
IgG1, but it was reduced in magnitude compared to the
Ls mice (Fig 1Ai). Thus co-infection with Pcc appeared
to down-regulate the anti-Ls specific IgG1 response. It
also appeared that responses in Pcc-Ls mice were further
biased toward a Th1 cell response through the induction
of IgG2a to LsA (Fig 1Aii). Also as expected [32,52], Pcc
mice mounted highly biased Th1-cell responses as indi-
cated by the predominance of Pcc (pRBC)-specific IgG2a
over IgG1 (Fig 1B). Once again, Pcc-Ls mice appeared to
alter this bias by increasing the amount of pRBC-specific
IgG1 in comparison to the Pcc mice (Fig 1Bi).
At first glance, the results strongly suggested that the
isotype and hence cytokine bias of each single-species
infection was significantly impacted by co-infection. In
support of this, polyclonal IgE was highest in Ls mice
a n da b s e n ti nPcc mice with Pcc-Ls mice exhibiting an
intermediate level (Fig. 1C) although Pcc-Ls mice did
not differ statistically from Ls mice in this polyclonal
analysis. However, it was apparent that Pcc mice were
exhibiting sizable antibody responses to LsA (X1 in Fig
1Aii) and conversely Ls mice were exhibiting strong
antibody responses to pRBC (X2 in Fig 1Bi). Western
blot analysis confirmed that these Ls-induced cross-reac-
tive responses were directed against the parasite rather
than the RBC (data not shown). We thus had to ask
w h e t h e rt h es h i f ta w a yf r o mL s A - s p e c i f i cI g G 1t o w a r d
IgG2a responses in the Pcc-Ls mice was due to the
influence of IFN-g on the Ls-induced response or simply
reflected the presence of cross-reactive Pcc-induced
IgG2a responses to LsA. Conversely, was the apparent
increase in pRBC-specific IgG1 responses in Pcc-Ls mice
due to Ls-induced antibodies that cross-reacted with
infected red blood cells? Because serum titres had not
been determined in this study, we could not assess the
relative strength of cross-reactive versus antigen-specific
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Page 4 of 12Figure 1 Antibody isotype responses in infection and co-infection with Litomosoides sigmodontis and malaria.M i c ew e r ei n f e c t e dw i t h2 5
Ls L3 larvae on day 0 and/or 10
6 Pcc-infected RBCs on day 60 post-Ls infection. Serum antibody responses measured by ELISA at day 80 post-Ls infection
to (A) Ls antigen (LsA) and (B) crude Pcc infected RBC antigen (pRBC). Th2 isotype IgG1 is shown in (Ai) and (Bi) whilst the Th1 associated isotype IgG2a
is shown in (Aii) and (Bii). Grey bars represent control mice, black bars represent Pcc mice, white bars the Ls mice and the chequered bars co-infected
mice (Pcc-Ls). The letter X highlights those responses that are cross-reactive. Groups not connected by the same letter denote pairs that are significantly
different according to Tukey’s Pairwise analysis while those that share the same letter do not differ significantly. (C) Polyclonal IgE responses. Black
squares represent Ls mice, white squares represent Pcc mice and grey squares represent co-infected (Pcc-Ls) mice. White circles indicate control animals.
Data shown in A & B are compiled from 3 experiments (control mice n = 13, Ls mice n = 37, Pcc mice n = 14, Pcc-Ls mice n = 41).
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cross-reactivity at the sera dilution tested thus con-
founded our ability to interpret any changes in immuno-
logical bias during Pcc-Ls co-infection.
Cross-reactive antibody responses are also observed
during malaria-Nippostrongylus brasiliensis co-infection
In order to address the utility of antibody isotype
responses further, we embarked on co-infection experi-
ments with Pcc and the nematode Nb. Because Pc-Nb is
an acute model, whereby the nematode is cleared by day
7 and the peak of malaria parasitemia is controlled by
day 10, the antibody data could be collected after only
20 days of co-infection, a more practical time frame
than the 80 days required for the Pcc-Ls experiments.
This also allowed us to address whether our observa-
tions of antibody cross-reactivity were a more general
feature of Pcc-nematode infection. Given the apparent
cross-reactivity observed at a fixed dilution of sera in
the Pcc-Ls ELISA we used endpoint titres derived from
a serial dilution (1:50 - 1:819200) in the Pcc-Nb assays
to address whether this readout would overcome cross-
reactivity problems. To determine if the specificity of
the assay could be improved with the use of recombi-
nant antigens we also included the malaria protein,
MSP-119 [39] not available to us for the Ls studies.
The antibody responses we observed on Day 20 of
Pcc-Nb co-infection (Fig 2) paralleled those we had seen
in the Pcc-Ls experiments at Day 80. For example, as
seen in Fig 2Aiii, Nb mice made IgG1 biased responses
against NbA, and responses in Pcc-Nb mice were inter-
mediate between Nb and Pcc mice. In addition, Pcc
mice mounted a strong MSP-119-specific IgG2a
response that was reduced in Pcc-Nb mice (Fig 2Bi). As
before, levels of polyclonal IgE in Pcc-Nb mice were
intermediate (data not shown). We again observed
cross-reactivity, whereby Nb mice mounted detectable
IgG1 and IgG2a responses to both recombinant and
crude malaria antigens (indicated by X1&2 in Fig 2A and
X4&5 in Fig 2B, respectively). The magnitude of the Nb-
induced IgG2a cross-reactive response is particularly
striking with titres against crude and recombinant
malaria antigens reaching 2500 and 200 respectively.
Similarly, Pcc mice mounted responses to NbA (X3 in
Fig 2A and X6 i nF i g2 B ) .I ti si m p o r t a n tt on o t et h a t
these titres although low are markedly greater than
background responses (mean plus 3 standard deviations
of serum responses from control mice), which are repre-
sented as zero on the y-axis. The immune bias that is
apparent in serum antibody isotype responses is fully
supported by cytokine responses in the lymph nodes of
Pcc-Nb infected mice as we have recently described [53].
Of interest, no cross-reactivity was observed at the T-
cell level.
Cross-reactive IgG1 responses of malaria-infected mice to
NbA are lost at higher dilutions but IgG2a responses
remain
The analysis of both Pcc-Ls and Pcc-Nb co-infection
indicates that the issue of cross-reactivity is a factor
investigators are likely to routinely encounter. Determin-
ing the qualitative and quantitative aspects of the cross-
reacting antibody responses are not only important for
the practical analysis of immune deviation but could be
of real biological relevance during co-infection.
As expected, antibody responses were biased, in terms
of isotype, by infection status. The bias in isotype due to
a particular infection (Th2 associated IgG1 induced dur-
ing Nb infection, for example) was extended to non-spe-
cific antigens, as seen in the IgG1 response of Nb mice
to both MSP-119 and pRBC (X1 and X2 in Fig 2Ai +
2Aii). However, Pcc-specific IgG2a titres in Pcc mice
were significantly higher than the cross-reactive
response induced in Nb mice (Fig 2Bi). Thus, although
Nb mice made cross-reactive IgG2a responses, these
were no longer detectable with increasing dilution of
sera (Fig 2Bi). In this case capitalising on the differences
in strength of antigen-specific and cross-reactive
responses clarified interpretation of immune bias in co-
infected mice. Similarly, IgG1 responses to NbA were
significantly higher in Nb mice than the cross-reactive
response induced by Pcc mice (Fig 2Aiii). However, titre
of Pcc-induced cross-reactive IgG2a to NbA did not dif-
fer significantly from Nb mice (X6 in Fig 2Biii).
We can conclude from this analysis that cross-reactive
IgG1 responses to NbA were only detectable at dilutions
less than 1:100 and thus higher dilutions may be used to
avoid cross-reactivity when assessing antigen-specific
antibody isotype profiles for the purpose of interpreting
immune bias. However, increasing sera dilution did not
always overcome the cross-reactivity observed, as IgG2a
responses to NbA in Pcc mice were still observed at
1:2500. This cross-reactivity warrants further investiga-
tion, as it is likely to be important biologically. Indeed
even cross-reactive responses detectable only at high
serum concentrations may still have functional relevance
in vivo.
Cross-reactivity appears to lie predominantly with
carbohydrate epitopes and can be largely eliminated by
periodate treatment
Antibody cross-reactivity in a broad range of systems
can be attributed to reactivity with carbohydrate deter-
minants [54,55]. Additionally, the IgG3 isotype is often
associated with recognition of carbohydrates [56] and
we observed cross-reactive IgG3 antibody responses
during Pcc-Nb co-infection (Fig. 3). Nb mice mounted
IgG3 responses to both MSP-119 and pRBC antigens,
achieving titres of 200 and 3200 respectively (Fig 3Ci
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responses to NbA (Fig 3Ciii). We thus chose to assess
whether cross-reactivity in our Pcc-Nb co-infection sys-
tem could be overcome by periodate treatment of the
parasite antigens. Periodate oxidises carbohydrate to
aldehydes, thus disrupting carbohydrate epitopes, which
allowed us to distinguish if cross-reactive responses tar-
get the carbohydrate or protein moiety of an antigen.
This could be of particular importance where detection
of cross-reactive responses was not overcome by
increasing serum dilution. In addition to clarifying the
interpretation of shifts in immune bias, determining
whether induction of specific isotype responses is driven
by protein or carbohydrate recognition has important
implications for vaccine design and diagnostic serology.
For the pRBC and MSP-119 antigens, periodate treat-
ment did not significantly affect recognition by IgG1
antibodies (P ≥ 0.7). Periodate treatment of NbA
however, significantly reduced anti-NbA IgG1 titres
across all infection groups (Fig 3Aiii), suggesting com-
mon recognition of a carbohydrate moiety. In particular,
the cross-reactive recognition of NbA, by IgG1 antibo-
dies from Pcc mice, was ablated (X7 in Fig 3Aiii).
Treatment of MSP-119 antigen with periodate resulted
in a significant increase in IgG2a detected in sera from
Pcc-Nb mice. Detection of IgG2a in singly-infected mice
also followed this trend but was not statistically signifi-
cant (Fig 3Bi). These results suggest recognition of a
protein epitope on the recombinant antigen previously
masked by glycosylation. Plasmodium species lack the
glycosyltransferases required for any glycosylation other
than attachment of GPI anchors [57,58]. However, inap-
propriate glycosylation of the recombinant protein can
occur in the Pichia expression system [57]. The increase
in protein-specific responses, following periodate treat-
ment of the recombinant antigen (MSP-119), may thus
Figure 2 Antibody isotype responses in infection and co-infection with Nippostrongylus brasiliensis and malaria. Mice were infected with
200 Nb L3 larvae and/or 10
5 Pcc-infected RBCs on day 0. Serum antibody titres (A) IgG1 (B) IgG2a to recombinant Pcc antigen MSP-119 (i), crude
Pcc antigen (pRBC) (ii) and crude Nb antigen (NbA) (iii) were measured at day 20 post-infection for 8 mice per infection group. Black bars
represent the Pcc mice, white bars the Nb mice and the chequered bars the co-infected mice (Pcc-Nb). Antibody titres are shown on the y-axis
and represent the reciprocal of the greatest dilution at which O.D was greater than the mean plus 3 standard deviations of the O.D values
observed for control mouse sera at a 1/200 dilution. The letter X highlights those responses that are cross-reactive. Groups not connected by the
same letter denote pairs that are significantly different according to Tukey’s Pairwise analysis.
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parasite protein seen during infection. IgG2a recognition
of periodate treated pRBC antigen was enhanced in sera
from Pcc mice, though not in the Pcc-Nb or Nb mice
(Fig 3Bii). This suggests the cross-reactive IgG2a
response is not targeting carbohydrates, which could
potentially be conserved amongst parasite antigens.
For NbA, it was only after treatment with periodate
that differences amongst infection groups become
apparent, whereby significantly greater amounts of
(cross-reactive) IgG2a antibodies were detected in Pcc
mice in comparison to Nb mice (X8 in Fig 3Biii). Thus,
the Pcc-induced cross-reactive IgG2a response to NbA
(X6 in Fig 2Biii) that was not lost with serial dilution
was also maintained following periodate treatment (X8
in Fig 3Biii). In contrast, the Nb-specific IgG2a response
appears to target carbohydrate as periodate treatment
reduced recognition of NbA in both Nb and Pcc-Nb
Figure 3 Antibody responses to protein epitopes in infection and co-infection with Nippostrongylus brasiliensis and malaria.T h e
parasite antigens used in ELISA were pre-treated with periodate to disrupt carbohydrate epitopes, in order to determine if cross-reactive
responses target the carbohydrate or protein moiety of an antigen. Mice were infected with 200 Nb L3 larvae and/or 10
5 Pcc-infected RBCs on
day 0. Serum antibody titres (y-axis) were measured at day 20 post-infection for 8 mice per infection group and represent the reciprocal of the
greatest dilution at which O.D was greater than the mean plus 3 standard deviations of the O.D values observed for control mouse sera at 1/200
dilution. Antibody isotypes (A) IgG1 (B) IgG2a (C) IgG3 to recombinant Pcc antigen MSP-119 (i), crude Pcc antigen (pRBC) (ii) and crude Nb antigen
(NbA) (iii) before (-) and after (+) treatment with periodate are shown. Black bars represent Pcc mice, white bars the Nb mice and the chequered
bars the co-infected (Pcc-Nb) mice. (*) denotes pairs which are significantly different according to Tukey’s pairwise analysis.
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Page 8 of 12mice (Fig 3Biii) although only statistically significant in
the Pcc-Nb mice. This may indicate that atypical Th1-
type responses to helminth antigens are driven by
carbohydrate.
Disruption of carbohydrates via periodate treatment
significantly affected the recognition of Pcc antigens by
IgG3 antibodies. In particular, recognition of periodate
treated pRBC was reduced in serum from all mice that
had experienced Pcc infection; this was most evident in
the Pcc-Nb mice (Fig 3Cii). The recognition of periodate
treated MSP1-19 was also significantly reduced in Pcc
mice (Fig 3Ci). The more pronounced reduction in IgG3
response to the treated pRBC antigen may reflect the
greater proportion of carbohydrate components in this
crude antigen preparation in comparison to the single
recombinant protein.
Discussion
Antibody analysis should be able to provide critical
information on changes in cytokine bias due to co-infec-
tion. This is particularly important in human studies
where serum may be the only reagent available for
immunological analysis. Whilst we acknowledge that
there is a need to confirm the relationship between sple-
nic or serum cytokines and antibody responses in co-
infection if this strategy is to be used in human studies,
our focus is on the interpretation of antigen-specific
Th1/Th2 bias based on antibody isotype, which was
complicated by cross-reactivity in the two co-infection
models studied here. It is worth noting that cross-reac-
tive responses were observed regardless of whether
recombinant or crude antigens were used. We primarily
address technical strategies that will enable us, and
others, to draw conclusions regarding the influence of a
co-infecting parasite on immune bias using serum anti-
bodies. However, the functional implications of cross-
reactive responses are also discussed.
Murine models that aim to dissect the real effect of a
co-infecting parasite on immune bias must use large
numbers of animals to detect significant differences in
antigen-specific responses between single and dual
infection. Thus for antibody analysis of the large sample
size (see legend Fig 1 for details) in our Pcc-Ls study of
co-infection we chose a fixed serum concentration, pre-
viously determined to fall within the linear range of the
dilution curve. Although this saved time and reagents,
in retrospect, it provided insufficient information for
our purposes: it did not allow us to distinguish the rela-
tive strengths of cross-reactive versus antigen-specific
responses.
W h e na n t i b o d yt i t r e sw e r ec a l c u l a t e di nt h ePcc-Nb
study, we were able to determine whether apparent
alterations in antibody isotype profile on co-infection
were due to actual changes in parasite-specific responses
or reflected a cross-reactive response. For example,
determining that cross-reactive IgG2a antibody titres in
Nb mice (X4 in Fig 2Bi) were significantly lower than
the antigen-specific response of Pcc mice meant that
cross-reactivity was unlikely to influence the titre
observed in Pcc-Nb mice. This allowed us to conclude
that the reduction in Th1 type antibody in Pcc-Nb mice
was probably due to suppression of Pcc-specific Th1
responses by nematode infection. Further to this, had
we not calculated titre and relied on optical density data
derived from a single dilution of sera we may not have
observed the difference between Pcc and Pcc-Nb mice
and thus incorrectly concluded that there was no effect
of co-infection on Th1 responses. Similarly, analysis of
antibody titre enabled us to detect the reduction in anti-
NbA IgG1 antibody in Pcc-Nb mice (Fig 2Aiii), which
suggests a Pcc-mediated bias toward a Th1 cell
response. In other cases, cross-reactivity was observed
even at high dilutions with Pcc mice achieving IgG2a
titres equivalent to or greater than Nb mice (X6 in Fig
2Biii). In this case, calculation of titre did not help to
unravel potential cytokine influences and the enhanced
IgG2a response in co-infected mice may be due to
increased Th1 cytokines during co-infection and/or the
presence of cross-reactive antibody (Fig 2Biii).
Nematode surface antigens and the excretory/secre-
tory products from these parasites are heavily glycosy-
lated [59]. Similarly, Plasmodium species express
glycoconjugates on their surface and have abundant gly-
cophosphatidylinositol anchors [60]. In other co-infec-
tion systems cross-reactive epitopes have been shown to
derive from carbohydrate structures [61]. The sensitivity
of the carbohydrate component of an antigen to period-
ate treatment [59] has been beneficial in interpreting
our results. In particular, treatment of Pcc antigens
demonstrated that cross-reactive nematode-induced
IgG3 responses were largely attributed to the carbohy-
drate component. Interestingly, periodate treatment also
reduced apparent cross-reactivity by exposure of protein
epitopes, previously masked by carbohydrate, which
enhanced the detection of antibodies from mice that
had been exposed to the antigen during infection (e.g.,
anti-pRBC in Fig 3Bii). This allowed us to conclude that
levels of anti-pRBC IgG2a antibody in Pcc-Nb mice are
solely induced by the Pcc parasite. Further to this, detec-
tion of cross-reactive protein-specific antibodies enabled
responses, previously indistinguishable in magnitude
between singly-infected groups, to be differentiated. For
example, periodate treatment of NbA enhanced detec-
tion of Pcc induced cross-reactive IgG2a antibodies (X8
in Fig 3Biii) whilst the antigen-specific response of Nb
mice was ablated. This indicates that the level of Nb-
specific IgG2a observed in Pcc-Nb mice is due to Pcc
driving a cross-reactive IgG2a Th1 type response.
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and periodate treatment of the parasite antigens can
help overcome cross-reactivity for the purposes of ana-
lysing and interpreting Th1/Th2 cell immune bias.
However, some ‘true’ cross-reactivity remained (i.e. Pcc-
induced IgG2a responses to NbA (Fig 2Biii/Fig 3Biii)),
and the induction of these antibodies has important
implications with regard to biological function. For
example the immune responses to nematode infection
are typically characterised by a Th2 type (IgG1)
response, as we observed for Nb-induced responses to
the nematode antigen (NbA). The propensity for Pcc
mice to induce atypical IgG2a antibody isotypes to
nematode antigen is likely due to the malaria parasite
promoting Th1 cytokines in the environment where the
antibody response is established [45]. The biological
consequences of the Pcc driven IgG2a response to the
nematode antigen and the less pronounced IgG1
response of Nb mice to Pcc antigens remain to be inves-
tigated. In Trichuris muris infection, manipulation of the
immune environment to a Th1 type setting, charac-
terised by elevated IgG2a and IFNg,w a ss h o w nt o
enhance chronicity of this intestinal helminth [62]. Pcc-
induced IgG2a to nematode antigens may thus have real
consequences in terms of disease outcome. Effects of
nematode co-infection on the malaria parasite are also
evident; Pcc-Nb mice have reduced levels of malaria
parasitemia in comparison to Pcc mice [53] and it is
interesting to consider the possibility that cross-reactive
IgG2a antibodies induced by the nematode infection
may act in concert with the antigen-specific response to
control malaria parasites. The potential for cross-reac-
tive responses to have a functional role during infection
raises the intriguing possibility that their production is a
deliberate strategy of the host to combat diverse para-
sites [63]. To fully understand the relative contribution
of cross-reactive antibodies in parasite control would
require passive antibody transfer experiments.
Although schistosome parasites are phylogenetically
distinct from nematodes, helminth co-infection studies
that investigate Schistosoma mansoni provide evidence
that cross-reactivity is relevant in other co-infection
systems and can have a strong impact on disease
severity. Naus et al [43] report the induction of cross-
reactive IgG3 antibodies that recognise both Plasmo-
dium falciparum and S. mansoni antigens. Pierrot et al
extended this study, identifying the S. mansoni antigen
(SmLRR) that is recognised by both malaria and S.
mansoni singly-infected hosts. Interestingly, as we
observed in our Pcc-Nb model of co-infection, the two
infections induce different antibody isotypes to antigen:
cross-reactive malaria driven IgG3 and helminth driven
IgG4 [45]. In areas co-endemic for these two parasites,
exposure to malaria and subsequent induction of the
cross-reactive IgG3 response seems to increase the risk
of developing hepatosplenomegaly in schistosome
infected individuals [44].
Conclusions
In summary, our data illustrate that whilst cross-reactiv-
ity may confound observations of interest, it can largely
be overcome by a combination of increasing sera dilu-
tion and pre-treatment of antigens with periodate.
Adopting such strategies will enable antibody isotypes to
be used as an indicator of cytokine bias and clarify
interpretation of when Th1-Th2 cell shifts have
occurred as a result of co-infection. Arising from this
analysis is the opportunity to dissect antigen-specific
from cross-reactive responses and thus obtain informa-
tion pertaining to the relative strength of these
responses and recognition of carbohydrate versus pro-
tein epitopes. This will provide the foundation on which
to base more detailed characterisation of the antibody
responses during co-infection in order to investigate
their functionality.
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